# Cullinan Therapeutics, Inc.: Form 8-K, filed Jun 27, 2024

- Company: [Cullinan Therapeutics, Inc.](/companies/cgem.md) (CIK 1789972)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 21:00 ET
- Period: 2024-06-26
- Accession: 0000950170-24-078554
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1789972/000095017024078554/cgem-20240626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1789972/000095017024078554/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1789972/000095017024078554/cgem-20240626.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-078554. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.